Asset Allocation

As of November 30, 2025.
Type % Net
Cash 0.76%
Stock 57.86%
Bond 40.73%
Convertible 0.00%
Preferred 0.00%
Other 0.65%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 73.62%
Mid 19.23%
Small 7.15%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.82%    % Emerging Markets: 0.54%    % Unidentified Markets: 0.65%

Americas 60.38%
60.38%
Canada 39.21%
United States 21.17%
0.00%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 24.69%
United Kingdom 7.25%
17.44%
Denmark 2.06%
Finland 5.91%
France 1.77%
Germany 0.92%
Ireland 1.65%
Switzerland 3.15%
0.00%
0.00%
Greater Asia 14.28%
Japan 9.61%
0.00%
4.43%
Hong Kong 2.61%
Singapore 1.82%
0.24%
China 0.24%
Unidentified Region 0.65%

Bond Credit Quality Exposure

AAA 31.72%
AA 21.35%
A 17.82%
BBB 22.17%
BB 2.50%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 4.45%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
36.09%
Materials
9.69%
Consumer Discretionary
8.49%
Financials
17.91%
Real Estate
0.00%
Sensitive
33.35%
Communication Services
4.47%
Energy
3.37%
Industrials
15.27%
Information Technology
10.23%
Defensive
9.19%
Consumer Staples
1.72%
Health Care
7.47%
Utilities
0.00%
Not Classified
21.37%
Non Classified Equity
0.00%
Not Classified - Non Equity
21.37%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 30.32%
Corporate 36.23%
Securitized 0.00%
Municipal 28.37%
Other 5.08%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.14%
Less than 1 Year
0.14%
Intermediate
65.45%
1 to 3 Years
12.79%
3 to 5 Years
15.85%
5 to 10 Years
36.81%
Long Term
33.46%
10 to 20 Years
6.93%
20 to 30 Years
19.05%
Over 30 Years
7.47%
Other
0.95%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial